Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
US11872274B2 · kind B2 · utility
0Cited by
57References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 6, 2021 |
| Grant date | Jan 16, 2024 |
| Priority date | — |
| Expiry date | Jan 27, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to new immunogenic compositions comprising conjugated Streptococcus pneumoniae capsular saccharide antigens (glycoconjugates) and uses thereof. Immunogenic compositions of the present invention will typically comprise at least one glycoconjugate from a S. pneumoniae serotype not found in PREVNAR®, SYNFLORIX® and/or PREVNAR 13®. The invention also relates to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said novel immunogenic compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.